Skip to content

A Safety and Effectiveness Study of a New Preservative Free Rewetting Drop

A Safety and Effectiveness Study of a New Preservative Free Rewetting Drop

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04175340
Enrollment
369
Registered
2019-11-25
Start date
2019-11-07
Completion date
2020-02-17
Last updated
2024-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contact Lens Wear

Brief summary

The objective of this study is to evaluate the safety and effectiveness of lubricating and rewetting drop (Test) compared to OPTI-FREE® Replenish® Rewetting Drops (Control) when used by habitual contact lens wearers to bilaterally lubricate and rewet soft (hydrophilic) contact lenses including silicone hydrogel contact lenses and gas permeable (silicone acrylate and fluoro silicone acrylate) contact lenses.

Interventions

DEVICEBL-300-PFM04

Preservative Free Lubricating and Rewetting Drops for use during contact lens wear

DEVICEOPTI-FREE

Replenish Rewetting Drops

Sponsors

Bausch & Lomb Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects must be of legal age (at least 18) on the date the Informed Consent Form (ICF) is signed and have the capacity to provide voluntary informed consent * Subjects must be habitual wearers of included contact lenses. * Subjects must be adapted lens wearers and wear a lens in each eye and each lens must be of the same manufacture and brand. * Subjects must agree to wear their lenses on a daily wear basis for approximately 1 month.

Exclusion criteria

• Subjects participating in any drug or device clinical investigation within two weeks prior to entry into this study and/or during the period of study participation.

Design outcomes

Primary

MeasureTime frameDescription
Overall Comfort Averaged Over All Follow-up Visits1 monthOverall comfort will be assessed for each eye on a scale from 0 to 100, with 100 denoting the most favorable response. For each eye, mean overall comfort over all follow-up visits will be computed as the average of the non-missing values overall scheduled follow-up visits.
Dryness Averaged Over All Follow-up Visits1 monthDryness will be assessed for each eye on a scale from 0 to 100, with 100 denoting the most favorable response. For each eye, mean dryness over all follow-up visits will be computed as the average of the non-missing values over all scheduled follow-up visits.
Proportion of Eyes With Slit Lamp Findings Greater Than Grade 2 at Any Follow-up Visit1 monthAt each follow-up visit, graded slit lamp findings will be assessed for each eye using Grades 0 through 4. Using only the non-missing observations from all visits without imputation, each eye will be classified with respect to findings greater than grade 2 at any visit (Absent, Present).

Countries

United States

Participant flow

Participants by arm

ArmCount
BL-300-PFM04
BL-300-PFM04: Preservative Free Lubricating and Rewetting Drops for use during contact lens wear
188
Lubricating and Rewetting Drops
OPTI-FREE: Replenish Rewetting Drops
181
Total369

Baseline characteristics

CharacteristicLubricating and Rewetting DropsTotalBL-300-PFM04
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
181 Participants369 Participants188 Participants
Age, Continuous33.7 Years
STANDARD_DEVIATION 8.57
34.6 Years
STANDARD_DEVIATION 9.13
35.6 Years
STANDARD_DEVIATION 9.56
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
27 Participants51 Participants24 Participants
Race (NIH/OMB)
Black or African American
21 Participants39 Participants18 Participants
Race (NIH/OMB)
More than one race
2 Participants4 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
130 Participants274 Participants144 Participants
Region of Enrollment
United States
181 participants369 participants188 participants
Sex: Female, Male
Female
57 Participants117 Participants60 Participants
Sex: Female, Male
Male
124 Participants252 Participants128 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1880 / 181
other
Total, other adverse events
0 / 1880 / 181
serious
Total, serious adverse events
0 / 1880 / 181

Outcome results

Primary

Dryness Averaged Over All Follow-up Visits

Dryness will be assessed for each eye on a scale from 0 to 100, with 100 denoting the most favorable response. For each eye, mean dryness over all follow-up visits will be computed as the average of the non-missing values over all scheduled follow-up visits.

Time frame: 1 month

ArmMeasureValue (MEAN)Dispersion
BL-300-PFM04Dryness Averaged Over All Follow-up Visits87.91 units on a scaleStandard Deviation 13.332
Lubricating and Rewetting DropsDryness Averaged Over All Follow-up Visits87.01 units on a scaleStandard Deviation 14.65
Primary

Overall Comfort Averaged Over All Follow-up Visits

Overall comfort will be assessed for each eye on a scale from 0 to 100, with 100 denoting the most favorable response. For each eye, mean overall comfort over all follow-up visits will be computed as the average of the non-missing values overall scheduled follow-up visits.

Time frame: 1 month

ArmMeasureValue (MEAN)Dispersion
BL-300-PFM04Overall Comfort Averaged Over All Follow-up Visits91.72 units on a scaleStandard Deviation 9.988
Lubricating and Rewetting DropsOverall Comfort Averaged Over All Follow-up Visits91.54 units on a scaleStandard Deviation 10.68
Primary

Proportion of Eyes With Slit Lamp Findings Greater Than Grade 2 at Any Follow-up Visit

At each follow-up visit, graded slit lamp findings will be assessed for each eye using Grades 0 through 4. Using only the non-missing observations from all visits without imputation, each eye will be classified with respect to findings greater than grade 2 at any visit (Absent, Present).

Time frame: 1 month

ArmMeasureValue (COUNT_OF_UNITS)
BL-300-PFM04Proportion of Eyes With Slit Lamp Findings Greater Than Grade 2 at Any Follow-up Visit0 Eyes
Lubricating and Rewetting DropsProportion of Eyes With Slit Lamp Findings Greater Than Grade 2 at Any Follow-up Visit0 Eyes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026